Astellas Pharma Inc.

Leading Practices

• No leading practice identified for this company. 

Changes Compared to Index 2008

• Astellas was not evaluated in Access to Medicine Index 2008.
• Astellas has at least two philanthropic programs focusing on HIV and measles in Angola and Liberia. The company discloses the financial resources dedicated to these projects.

Suggested Areas for Improvement

• Astellas is below average on ATM strategies, public reporting of policies, objectives & performance and formal representation of ATM issues at senior management level.
• The company has no R&D activities for Neglected Tropical Diseases (NTDs), contrary to other Japanese companies such as Eisai.
• Astellas has several products for Non-Communicable Index Diseases (e.g. diabetes, unipolar depressive disorder) in its portfolio, but no ATM initiatives aimed at more active registration and distribution of such products in the Index Countries.